SCHEMBL61654

SCHEMBL61654

NC1(OC=O)CCCCC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62222 1.00 TSHR (0.32) TSHRCYP2C19
SCHEMBL60474 1.00 TSHR (0.32) TSHRCYP2C19
Hydrochloric Acid SCHEMBL9009933 0.97 TSHR (0.31) TSHRCYP2C19
SCHEMBL61974 0.97
Hydrochloric Acid SCHEMBL3168559 0.95
SCHEMBL61735 0.92
SCHEMBL61083 0.86
Hydrochloric Acid SCHEMBL8681308 0.83
Hydrochloric Acid SCHEMBL5960763 0.81
SCHEMBL4441457 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3230 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025069009-A1 ROCK2 INHIBITORS IN THE TREATMENT OF OBESITY GRAVITON BIOSCIENCE BV (NL) 2025-04-03 WO claimed
CN-118937682-B Kit for heparin binding protein detection and preparation method thereof 浙江夸烨生物科技有限公司 2025-02-11 CN claimed
CN-119119207-A Phase separated polypeptide and GLP-1 RAs derivative containing same 北京化工大学 2024-12-13 CN claimed
CN-118994411-A High-stability long-acting GLP-1 RAs derivative 北京化工大学 2024-11-22 CN claimed
CN-118937682-A Kit for heparin binding protein detection and preparation method thereof 浙江夸烨生物科技有限公司 2024-11-12 CN claimed
CN-118843638-A CRF2 receptor agonists and their use in therapy 科尔特瑞制药公司 2024-10-25 CN claimed
CN-117778530-A Method for adding preset joint to 5' end of single-stranded DNA 清华大学 2024-03-29 CN claimed
EP-3250191-B1 TABLETS COMPRISING GLP-1 AGONIST AND ENTERIC COATING NOVO NORDISK AS (DK) 2024-01-17 EP claimed
CN-117174924-A Non-noble metal catalyst, preparation method thereof, fuel cell and automobile 一汽解放汽车有限公司 2023-12-05 CN claimed
US-20230340025-A1 Treatments for Gastrointestinal Disorders WELLS FARGO BANK, NATIONAL ASSOCIATION 2023-10-26 US claimed
WO-2002016407-A2 SH2 DOMAIN BINDING INHIBITORS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-02-28 WO claimed
WO-2002012278-A2 PSEUDO-METALLOPROTEINS, CORRESPONDING PREPARATION AND USE AS BIOSENSORS UNIVERSITA' DEGLI STUDI DI NAPOLI 'FEDERICO II' (IT) 2002-02-14 WO claimed
EP-1163262-A1 PHENYLALANINE DERIVATIVES THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2001-12-19 EP claimed
WO-2001000655-A2 THERAPEUTIC PEPTIDES DERIVED FROM SUBSEQUENCES OF BPI XOMA TECHNOLOGY LTD. (US) 2001-01-04 WO claimed
WO-2001000671-A1 DERIVATIVE COMPOUNDS XOMA TECHNOLOGY LTD. (US) 2001-01-04 WO claimed
WO-2000056760-A1 PHENYLALANINE DERIVATIVES THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-09-28 WO claimed
US-5385910-A Gem-distributed esters of rapamycin AMERICAN HOME PRODUCTS CORPORATION (US) 1995-01-31 US claimed
US-4833152-A Anti-hypertensive agents UNIVERSITY OF MIAMI (US) 1989-05-23 US claimed
EP-0036713-B1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS UNIVERSITY OF MIAMI (US) 1984-01-18 EP claimed
EP-0036713-A2 Angiotensin converting enzyme inhibitors UNIVERSITY OF MIAMI (US) 1981-09-30 EP claimed